Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis.
Ebolavirus species Zaire (ZEBOV) causes highly lethal hemorrhagic fever, resulting in the death of 90% of patients within days. Most information on immune responses to ZEBOV comes from in vitro studies and animal models. The paucity of data on human immune responses to this virus is mainly due to th...
Saved in:
Main Authors: | Nadia Wauquier (Author), Pierre Becquart (Author), Cindy Padilla (Author), Sylvain Baize (Author), Eric M Leroy (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2010-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biosafety level-2 laboratory diagnosis of Zaire Ebola virus disease imported from Liberia to Nigeria
by: Olumuyiwa B. Salu, et al.
Published: (2016) -
Lymphocyte chromosomal aberration assay in radiation biodosimetry
by: Paban K Agrawala, et al.
Published: (2010) -
A two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaks
by: Georgi Shukarev, et al.
Published: (2017) -
Accounting for population structure reveals ambiguity in the Zaire Ebolavirus reservoir dynamics.
by: Bram Vrancken, et al.
Published: (2020) -
First laboratory confirmation and sequencing of Zaire ebolavirus in Uganda following two independent introductions of cases from the 10th Ebola Outbreak in the Democratic Republic of the Congo, June 2019.
by: Luke Nyakarahuka, et al.
Published: (2022)